Metastasis-Associated Protein 1 Deficiency Results in Compromised Pulmonary Alveolar Capillary Angiogenesis in Mice

Jun-Hui Qin1, Zhen-Yu Ke1, Qiang Zhou2

  • 1Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China (mainland).

Insights

Metastasis-associated protein 1 (MTA1) deficiency impairs pulmonary capillary formation by reducing HIF-1α and VEGF. MTA1 is crucial for lung development and may offer new diagnostic and therapeutic targets for pulmonary diseases.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Developmental Biology

Background:

  • Metastasis-associated protein 1 (MTA1) plays a role in cellular processes.
  • Its specific function in pulmonary angiogenesis and lung development is not fully understood.

Purpose of the Study:

  • To investigate the role of MTA1 in pulmonary alveolar capillary angiogenesis in mice.
  • To elucidate the molecular mechanisms underlying MTA1's function in lung development.

Main Methods:

  • MTA1 deficiency was studied in MTA1-knockout (KO) mice compared to wild-type controls.
  • Gene and protein expression analysis (MTA1, CD34, VEGF, α-SMA, HIF-1α) using qPCR, immunoblotting, and immunohistochemistry.
  • Morphological, physiological (heart weight/body weight ratio, cardiomyocyte size), and in vitro studies were performed.

Main Results:

  • MTA1 deficiency led to reduced pulmonary alveolar capillaries and decreased expression of HIF-1α and VEGF.
  • MTA1-KO mice showed retarded growth, increased infant mortality, and myocardial hypertrophy in survivors.
  • In vitro, MTA1 overexpression upregulated HIF-1α and VEGF levels.

Conclusions:

  • MTA1 is essential for pulmonary capillary formation, likely through stabilizing HIF-1α.
  • MTA1 influences lung development and may be a target for treating pulmonary diseases.